67-year-old woman diagnosed with an infiltrating ductal carcinoma of the breast and no family history of neoplasia. What additional studies should be performed on the tumor for its clinical-therapeutic implications?
All breast carcinomas should be accompanied by the study of hormone receptors and HER-2 for the prognostic implications of the tumor, as well as the adequacy of the treatment of the same, since depending on the result will apply some drugs or others. The study of relatives and the BCRA gene is not indicated since she does not have a family history of neoplasia.
Complete phenotypic study by flow cytometry.
Study of hormone receptors and HER2.
Study of hormone receptors, e-cadherin and study of first-degree relatives.
BRCA 1-2 study and study of first-degree relatives.
All breast carcinomas should be accompanied by the study of hormone receptors and HER-2 for the prognostic implications of the tumor, as well as the adequacy of the treatment of the same,
The study of relatives and the BCRA gene is not indicated since she does not have a family history of neoplasia.
The study of relatives and the BCRA gene is not indicated since she does not have a family history of neoplasia.